toripalimab-tpzi 240 MG in 6 ML Injection

RxCUI: 2669413
RxNorm name: toripalimab-tpzi 240 MG in 6 ML Injection
Display name: toripalimab-tpzi 240 MG in 6 ML Injection
Full name: toripalimab-tpzi 240 MG in 6 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761240	Loqtorzi	toripalimab-tpzi	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
LOQTORZI	TORIPALIMAB-TPZI	Coherus Oncology, Inc.	82e7921a-1e84-4988-9799-0ad7d19b2a75	2026-07-23	Warnings, Adverse reactions	Exact identifier rxcui: 2669413

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
82e7921a-1e84-4988-9799-0ad7d19b2a75	toripalimab-tpzi 240 MG in 6 ML Injection	PSN	8	These highlights do not include all the information needed to use LOQTORZI safely and effectively. See full prescribing information for LOQTORZI. LOQTORZI ® (toripalimab-tpzi) injection, for intravenous use Initial U.S. Approval: 2023	20260105
82e7921a-1e84-4988-9799-0ad7d19b2a75	6 ML toripalimab-tpzi 40 MG/ML Injection	SCD	8	These highlights do not include all the information needed to use LOQTORZI safely and effectively. See full prescribing information for LOQTORZI. LOQTORZI ® (toripalimab-tpzi) injection, for intravenous use Initial U.S. Approval: 2023	20260105
82e7921a-1e84-4988-9799-0ad7d19b2a75	toripalimab-tpzi 240 MG per 6 ML Injection	SY	8	These highlights do not include all the information needed to use LOQTORZI safely and effectively. See full prescribing information for LOQTORZI. LOQTORZI ® (toripalimab-tpzi) injection, for intravenous use Initial U.S. Approval: 2023	20260105